96 related articles for article (PubMed ID: 14971044)
1. Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3.
Pishko EJ; Kirimanjeswara GS; Pilione MR; Gopinathan L; Kennett MJ; Harvill ET
Eur J Immunol; 2004 Jan; 34(1):184-93. PubMed ID: 14971044
[TBL] [Abstract][Full Text] [Related]
2. pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.
Pilione MR; Pishko EJ; Preston A; Maskell DJ; Harvill ET
Infect Immun; 2004 May; 72(5):2837-42. PubMed ID: 15102794
[TBL] [Abstract][Full Text] [Related]
3. The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4.
Kirimanjeswara GS; Mann PB; Pilione M; Kennett MJ; Harvill ET
J Immunol; 2005 Dec; 175(11):7504-11. PubMed ID: 16301658
[TBL] [Abstract][Full Text] [Related]
4. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.
Wolfe DN; Kirimanjeswara GS; Harvill ET
Infect Immun; 2005 Oct; 73(10):6508-13. PubMed ID: 16177324
[TBL] [Abstract][Full Text] [Related]
5. Comparative role of immunoglobulin A in protective immunity against the Bordetellae.
Wolfe DN; Kirimanjeswara GS; Goebel EM; Harvill ET
Infect Immun; 2007 Sep; 75(9):4416-22. PubMed ID: 17591791
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica.
Gopinathan L; Kirimanjeswara GS; Wolfe DN; Kelley ML; Harvill ET
Microbes Infect; 2007 Apr; 9(4):442-8. PubMed ID: 17317263
[TBL] [Abstract][Full Text] [Related]
7. Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica.
Sukumar N; Love CF; Conover MS; Kock ND; Dubey P; Deora R
Infect Immun; 2009 Feb; 77(2):885-95. PubMed ID: 19064638
[TBL] [Abstract][Full Text] [Related]
8. Host Specificity of Ovine Bordetella parapertussis and the Role of Complement.
Hester SE; Goodfield LL; Park J; Feaga HA; Ivanov YV; Bendor L; Taylor DL; Harvill ET
PLoS One; 2015; 10(7):e0130964. PubMed ID: 26158540
[TBL] [Abstract][Full Text] [Related]
9. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.
Pilione MR; Harvill ET
Infect Immun; 2006 Feb; 74(2):1043-9. PubMed ID: 16428751
[TBL] [Abstract][Full Text] [Related]
10. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis.
Hellwig SM; van Oirschot HF; Hazenbos WL; van Spriel AB; Mooi FR; van De Winkel JG
J Infect Dis; 2001 Mar; 183(6):871-9. PubMed ID: 11237803
[TBL] [Abstract][Full Text] [Related]
11. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
Bode J; Dutow P; Sommer K; Janik K; Glage S; Tümmler B; Munder A; Laudeley R; Sachse KW; Klos A
PLoS One; 2012; 7(11):e50327. PubMed ID: 23189195
[TBL] [Abstract][Full Text] [Related]
12. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
Kerr AR; Paterson GK; Riboldi-Tunnicliffe A; Mitchell TJ
Infect Immun; 2005 Jul; 73(7):4245-52. PubMed ID: 15972516
[TBL] [Abstract][Full Text] [Related]
13. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C
Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407
[TBL] [Abstract][Full Text] [Related]
14. Regulation of murine splenic B cell CR3 expression by complement component 3.
Jacobson AC; Roundy KM; Weis JJ; Weis JH
J Immunol; 2009 Sep; 183(6):3963-70. PubMed ID: 19710459
[TBL] [Abstract][Full Text] [Related]
15. Complement component C3 is required for protective innate and adaptive immunity to larval strongyloides stercoralis in mice.
Kerepesi LA; Hess JA; Nolan TJ; Schad GA; Abraham D
J Immunol; 2006 Apr; 176(7):4315-22. PubMed ID: 16547268
[TBL] [Abstract][Full Text] [Related]
16. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.
Mann P; Goebel E; Barbarich J; Pilione M; Kennett M; Harvill E
Infect Immun; 2007 Jul; 75(7):3665-72. PubMed ID: 17452472
[TBL] [Abstract][Full Text] [Related]
17. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy.
Wozencraft AO; Sayers G; Blackwell JM
J Exp Med; 1986 Oct; 164(4):1332-7. PubMed ID: 3531384
[TBL] [Abstract][Full Text] [Related]
18. The role of C3 in mediating binding and ingestion of group B streptococcus serotype III by murine macrophages.
Noel GJ; Katz SL; Edelson PJ
Pediatr Res; 1991 Jul; 30(1):118-23. PubMed ID: 1891276
[TBL] [Abstract][Full Text] [Related]
19. CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection.
Pilione MR; Agosto LM; Kennett MJ; Harvill ET
Cell Microbiol; 2006 May; 8(5):758-68. PubMed ID: 16611225
[TBL] [Abstract][Full Text] [Related]
20. Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages.
Abe Y; Kuroda Y; Kuboki N; Matsushita M; Yokoyama N; Kojima N
J Biochem; 2008 Nov; 144(5):563-70. PubMed ID: 18694897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
